Clinical Trial Details

Trial ID: L0630
Source ID: ChiCTR-TRC-14004464
Associated Drug: Liraglutide
Title: Efficacy of liraglutide QD vs. sitagliptin QD vs. insulin glargine on liver fat when combined with metformin in T2DM subjects with NAFLD
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Type 2 Diabetes Mellitus Complicated With Non-alcoholic Fatty Liver Disease
Interventions: 1:Liraglutide;2:Sitagliptin;3:Insulin glargine;
Outcome Measures: Intrahepatic Lipids;Abdominal Subcutaneous Adipose Tissue;Visceral Adipose Tissue;Body Weight;Body Mass Index;Circumstance;Heamoglobin A1c;Fasting Plasma Glucose;Postprandial Plasma Glucose;Fasting Plasma Lipid;Blood Pressure;Hypoglycemia Incidence;Adverse Event;Hematological Examination;Biochemical Test;Urine Analysis;
Sponsor/Collaborators: The 3rd Affiliated Hospital of Sun-Yat Sen University
Gender: All
Age: 3075
Phases: Other
Enrollment: 1:50;2:50;3:50;
Study Type: Interventional study
Study Designs: Randomized parallel controlled trial
Start Date: 18/03/2014
Completion Date: --
Results First Posted: --
Last Update Posted: 18 April 2017
Locations: China
URL: http://www.chictr.org.cn/showproj.aspx?proj=5106